Considerations on our 2013 impact factor  by Santos, Cid Aimbiré de Moraes
Rev Bras Farmacogn 24(2014): 367
0102-695X/$ - see front matter © 2014 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editora Ltda. All rights reserved.
http://dx.doi.org/10.1016/j.bjp.2014.09.001
Our 2013 Impact Factor has risen to 0.796, from last year’s 0.676. 
This result demonstrates that Brazilian Journal of Pharmacognosy 
continues to grow from strength to strength. The current 87% 
growth is due to citations derived from other journals, and only 
13% is due to self-citations. 
Among the more than 100 Brazilian scientific journals 
indexed to ISI, BJP is in the 34th place and has the highest 
impact factor among those in the field of Pharmacy, which 
puts us in an excellent position among the top journals in 
the country.
Thank you to all who have contributed to the journal’s 
success so far: to our authors, who continue to send us their 
research and let us publish their work; to our referees, whose 
efforts continue to be as guardians of quality of what is 
published; to our readers, especially those that repay us by 
informing us about the problems and advise us on how to 
grow; and to our Editorial and Advisory Boards, whose work is 
priceless. We are very grateful for your support.
The growth of our journal is quite evident when 
we access recently published data in the SCImago 
website (http://www.scimagojr.com/journalsearch.
php?q=5400152628&tip=sid&exact=no).  In the category of 
Pharmacology, Toxicology, and Pharmaceutics (miscellaneous), 
we reached the Q1 quartile, the highest value. 
To keep our journal progressive is a never-ending and 
obstinate process. There is still much work to be done and a 
long way to go to reach the vital impact in the area of natural 
products and pharmacognosy. 
We are also meeting our challenges step by step. 
However, we need massive and constant cooperation from 
reviewers. They bring the required contribution to improve 
the manuscripts and, furthermore, with their expertise, they 
are the real actors that contribute to the growth of science. 
Whenever a manuscript receives a critique or a contribution to 
improve the results, when a question is asked or a compliment 
given, all aspects of the review are valuable to improve the 
article and, hence, improve the quality of the journal’s 
publications. Then, the researchers must understand that the 
review of manuscripts is an important aspect of the scientific 
work to allow the growth of science. Science only grows with 
the contribution of its peers.
Brazilian scientific journals have yet another problem to 
overcome. First, we have to realize that the BJP is published 
today in partnership with Elsevier and the articles are 
available Open Access in two of the most important scientific 
portals (Science Direct and SciElo Brazil), which gives a great 
international visibility to publications. Second, the graphic 
quality of our journal does not owe any international journal, 
as it is today. However, authors do not appear to recognize 
this. They still initially seek to publish their articles in 
journals abroad, some with very high costs, rather than 
looking primarily to Brazilian journals. This problem is, to our 
understanding, a cultural issue in Brazil, and it is one that we 
have to overcome. As we look at the recently published JCR, 
only one Brazilian journal has an IF above 2.0. It is hard to grow 
if Brazilian authors do not consider Brazilian journals as their 
first choice to publish the results of the research. The financial 
efforts made by the Publications Program of the MCT/CNPq/
CAPES will only be all-inclusive, and national journals could 
achieve better indices in the next few years if we increase 
credibility among Brazilian authors.
As a closing remark, again I would like to express a special 
gratitude to the Associate Editors for their dedication, creativity, 
and help in making our journal the special publication it is today.
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